PHASE-I CLINICAL-STUDY OF N-(PHOSPHONACETYL)-L-ASPARTIC ACID (PALA)
- 1 January 1980
- journal article
- research article
- Vol. 64 (2-3) , 285-292
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- ENZYMATIC ASSAY FOR THE ANTI-TUMOR AGENT N-(PHOSPHONACETYL)-L-ASPARTIC ACID (PALA)1979
- Comparison of the activity of 2′-deoxycoformycin and erythro-9-(2-hydroxy-3-nonyl)adenine in vivoBiochemical Pharmacology, 1979
- EFFECTS OF N-(PHOSPHONACETYL)-L-ASPARTATE ON MURINE TUMORS AND NORMAL TISSUES INVIVO AND INVITRO AND RELATIONSHIP OF SENSITIVITY TO RATE OF PROLIFERATION AND LEVEL OF ASPARTATE-TRANSCARBAMYLASE1978
- Reversal of toxicity and antitumor activity of N-(phosphonacetyl)-L-aspartate by uridine or carbamyl-DL-aspartate in vivoBiochemical Pharmacology, 1977
- ANTITUMOR ACTIVITY OF N-(PHOSPHONACETYL)-L-ASPARTIC ACID, A TRANSITION-STATE INHIBITOR OF ASPARTATE-TRANSCARBAMYLASE1976